Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program

  1. Yubero, A.
  2. Estévez, P.
  3. Barquín, A.
  4. Sánchez, L.
  5. Santaballa, A.
  6. Pajares, B.
  7. Reche, P.
  8. Salvador, C.
  9. Manso, L.
  10. Márquez, R.
  11. González-Martín, A.
Journal:
Gynecologic Oncology Reports

ISSN: 2352-5789

Year of publication: 2023

Volume: 48

Type: Article

DOI: 10.1016/J.GORE.2023.101211 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus